Live Oak Bancshares heads into the back half of August with options traders at their most cautious in a year and the company's founder continuing to trim his stake — a combination worth watching even as the broader short positioning stays modest.
The clearest tension this week is in options. The put/call ratio has climbed to 1.12, a 52-week high and well above its 20-day average of 0.85. Running roughly 1.4 standard deviations above that average, the reading marks a decisive pivot from the bullish options skew that dominated through July, when the PCR sat as low as 0.11. That earlier period coincided with the post-earnings rally; the rotation toward puts since early August suggests hedging demand has picked up meaningfully as the stock has pulled back. LOB closed at $42.60 on Tuesday, down 1.6% on the day and roughly flat for the week, underperforming most correlated peers — FNB, UBSI, and AUB each gained 0.5–0.8% over the same five sessions.
Short positioning tells a quieter story. SI holds at roughly 4.2% of free float — meaningful but not extreme, and actually down about 1.1% on the week after spending most of July and early August near the same level. Borrowing conditions reflect the absence of real squeeze pressure: cost to borrow is just 0.37%, and availability is wide open at over 1,000% of current short interest, meaning there is far more stock available to lend than there are shorts to borrow it. The ORTEX short score has drifted up to 49.3, near the middle of its range — not a signal that short sellers are building a conviction position.
On the Street, the direction of analyst travel has been uniformly constructive since Q2 earnings dropped in late July. KBW raised its Outperform target to $47 and TD Cowen lifted its Buy target to $49. This morning, Cantor Fitzgerald raised its target a dollar to $45 while holding a Neutral rating — the most recent move, and a reminder that not everyone is convinced the stock earns a premium. The mean target sits at $46.25, implying about 8.6% upside from current levels. Bulls lean on Live Oak's SBA lending dominance and its technology-driven deposit franchise; bears flag credit risk, potential regulatory headwinds on SBA programs, and a valuation that has re-rated materially — the P/E multiple has compressed about 0.15 turns over 30 days even as the stock held up. EPS momentum ranks in the 87th percentile on a 90-day basis, a genuine positive, though the 12-month forward EPS growth outlook scores in just the 22nd percentile.
The insider picture is the most pointed data point this week. Founder and Chairman/CEO James Mahan sold 10,000 shares on each of August 12 and 13, averaging just over $43 — roughly $858,000 in aggregate. Executive Chairman William Williams sold 8,400 shares on August 3 for about $362,000. CFO William Losch received a 42,000-share award on August 10 and immediately sold 18,665 shares for roughly $788,000. The 90-day net insider figure is technically positive at $6.75 million — skewed by the award transactions — but stripping out the zero-cost grants, the cash selling from the company's two most senior executives is a consistent theme. Mahan remains the second-largest individual holder with nearly 13.6% of shares, so these clips are small relative to his position, but the cadence is worth noting given the stock is trading near its 52-week highs.
The next earnings event is scheduled for October 21. That print will land after a quarter in which the stock has traded at elevated valuations relative to its recent history, and with options positioning already more defensive than at any point in the past year. How NIM trends and SBA loan volume hold up through the rate environment will be the key variables when the quarter is reported.
See the live data behind this article on ORTEX.
Open LOB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
